Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June:

Citi Biotech Virtual Co-Panel Day May 18 at 3:30 p.m. ET. This presentation will be closed to conference participants only.

H.C. Wainwright Global Investment Conference Available on demand starting May 24 at 7:00 a.m. ET. Webcast Link: https://journey.ct.events/view/f447a79f-2d56-40f1-9924-e6b53707d9c1

Jefferies Global Healthcare Conference June 9 at 3:30 p.m. ET in New York, N.Y. Webcast Link: https://wsw.com/webcast/jeff240/mrns/1869600

16th EILAT Conference on New Antiepileptic Drugs and Devices May 22 – 25 in Madrid, Spain This event is closed to conference participants only.

Epilepsy Foundation Pipeline Conference June 6 at 6:20 p.m. ET / 3:20 p.m. PT in Santa Clara, Calif. This presentation will be closed to conference participants only.

About Marinus Pharmaceuticals Marinus is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a neuroactive steroid GABAA receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects. It is being developed in IV and oral dose formulations intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings. For more information visit www.marinuspharma.com.

Sasha Damouni Ellis Vice President, Corporate Affairs & Investor Relations Marinus Pharmaceuticals, Inc. 484-253-6792 sdamouni@marinuspharma.com

Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Marinus Pharmaceuticals Charts.
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Marinus Pharmaceuticals Charts.